These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Early prediction of endocrine therapy effect in advanced breast cancer patients using 99mTc-depreotide scintigraphy. Van Den Bossche B; Van Belle S; De Winter F; Signore A; Van de Wiele C J Nucl Med; 2006 Jan; 47(1):6-13. PubMed ID: 16391181 [TBL] [Abstract][Full Text] [Related]
3. 99mTc depreotide scan compared with 99mTc-MDP bone scintigraphy for the detection of bone metastases and prediction of response to hormonal treatment in patients with breast cancer. Van Den Bossche B; D'haeninck E; De Winter F; Van Belle S; Dierckx RA; Van De Wiele C Nucl Med Commun; 2004 Aug; 25(8):787-92. PubMed ID: 15266172 [TBL] [Abstract][Full Text] [Related]
4. [Somatostatin in breast cancer]. Frati A; Antoine M; Rodenas A; Gligorov J; Rouzier R; Chéreau E Ann Biol Clin (Paris); 2011; 69(4):385-91. PubMed ID: 21896402 [TBL] [Abstract][Full Text] [Related]
5. Can quantifying hormone receptor levels guide the choice of adjuvant endocrine therapy for breast cancer? Mackey JR J Clin Oncol; 2011 Apr; 29(12):1504-6. PubMed ID: 21422423 [No Abstract] [Full Text] [Related]
6. The potential role of somatostatin analogues in breast cancer treatment. Pollak M Yale J Biol Med; 1997; 70(5-6):535-9. PubMed ID: 9825480 [TBL] [Abstract][Full Text] [Related]
7. Somatostatin receptors and breast cancer. Cameron Smith M; Orlando C; Serio M; Maggi M J Endocrinol Invest; 2003; 26(8 Suppl):125-30. PubMed ID: 15233228 [No Abstract] [Full Text] [Related]
8. Somatostatin receptor scintigraphy of a patient with a giant invasive prolactinoma. Meyer P; Bohnen NI; Barkan AL; Shapiro B Nuklearmedizin; 1999; 38(2):66-7. PubMed ID: 10100234 [TBL] [Abstract][Full Text] [Related]
9. Mammographic Density as a Biosensor of Tamoxifen Effectiveness in Adjuvant Endocrine Treatment of Breast Cancer: Opportunities and Implications. Mullooly M; Pfeiffer RM; Nyante SJ; Heckman-Stoddard BM; Perloff M; Jatoi I; Brinton LA; Aiello Bowles EJ; Hoover RN; Glass A; Berrington de Gonzalez A; Sherman ME; Gierach GL J Clin Oncol; 2016 Jun; 34(18):2093-7. PubMed ID: 27022110 [No Abstract] [Full Text] [Related]
10. [Neuroendocrine carcinoma of the breast. Our experience and a proposal of a therapeutic algorithm for a rare tumor]. Scaramuzzi G; Murgo RM; Cuttitta A; Ciuffreda L G Chir; 2008 May; 29(5):203-6. PubMed ID: 18507954 [TBL] [Abstract][Full Text] [Related]
11. The role of tamoxifen in hospice: pros and cons. Herndon CM; Arayath J; Hallin P Am J Hosp Palliat Care; 2001; 18(2):133-4. PubMed ID: 11407130 [No Abstract] [Full Text] [Related]
12. Somatostatin receptor imaging in somatotroph and non-functioning pituitary adenomas: correlation with hormonal and visual responses to octreotide. Broson-Chazot F; Houzard C; Ajzenberg C; Nocaudie M; Duet M; Mundler O; Marchandise X; Epelbaum J; Gomez De Alzaga M; Schäfer J; Meyerhof W; Sassolas G; Warnet A Clin Endocrinol (Oxf); 1997 Nov; 47(5):589-98. PubMed ID: 9425399 [TBL] [Abstract][Full Text] [Related]